U.S. AstraZeneca Trial Finds Vaccine Is 79 Percent Effective Against Covid | NBC News NOW
A Phase 3 trial of the AstraZeneca vaccine conducted in the U.S. found that the Covid-19 vaccine was 79 percent effective against symptomatic illness and 100 percent effective in stopping…